Consensus Liquidia Corporation

Equities

LQDA

US53635D2027

Real-time Estimate Cboe BZX Other stock markets 02:53:23 2024-05-15 pm EDT			5-day change	1st Jan Change
12.12 ^USD	+1.30%		-2.80%	+1.00%

02:01am	Transcript : Liquidia Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM
May. 14	Transcript : Liquidia Corporation, Q1 2024 Earnings Call, May 14, 2024

Evolution of the average Target Price on Liquidia Corporation

Price target over the last 5 years

History of analyst recommendation changes

ea29130db84c2e9.zqhIss1w-Y7GNeoutGBgLpDV5uR2fSmFNYzp-Q7hD-0._5A865wji8Gfc5Bm0CoESKGay5wiDV_aV7mGoz3SbKSN0h3mlDqIwpZ7gQ~cb125d861b498b73ea3a2a6c29f2cb07

Analyst Recommendations on Liquidia Corporation

Liquidia Insider Sold Shares Worth $452,183, According to a Recent SEC Filing	Mar. 20	MT
HC Wainwright Adjusts Price Target on Liquidia to $32 From $16, Maintains Buy Rating	Mar. 14	MT
BofA Securities Raises Price Target on Liquidia to $15 From $13, Maintains Buy Rating	Dec. 21	MT
Needham Adjusts Price Target on Liquidia to $18 From $16, Maintains Buy Rating	23-03-17	MT
Needham Raises Liquidia's Price Target to $16 From $12, Maintains Buy Rating	22-09-01	MT
Wedbush Lowers Liquidia to Underperform From Neutral, Price Target to $3 From $4 on Adjusted Yutrepia Timeline	22-09-01	MT
Ladenburg Thalmann Initiates Coverage of Liquidia at Buy with $15 Price Target	22-07-22	MT
BTIG Adjusts Liquidia's Price Target to $17 From $14, Reiterates Buy Rating	22-07-20	MT
BTIG Starts Liquidia at Buy With $14 Price Target	22-05-31	MT
BofA Securities Starts Liquidia at Buy With $12 Price Target	22-05-26	MT
Wedbush Cuts Price Target on Liquidia Technologies to $4 From $6, Following Tyvaso Regulatory Update, Maintains Neutral Rating	22-05-24	MT
Wedbush Cuts Price Target on Liquidia Technologies to $4 From $6, Citing Tyvaso Market Penetration Estimates, Maintains Neutral Rating	22-05-24	MT
HC Wainwright Adjusts Liquidia Technologies' Price Target to $16 From $6, Keeps Buy Rating	22-02-03	MT
Needham Adjusts Liquidia Technologies' Price Target to $12 from $8, Keeps Buy Rating	22-01-10	MT
Wedbush Lifts Liquidia Technologies' Price Target to $6 From $2; Neutral Rating Kept	21-11-09	MT
LIQUIDIA : Wedbush Adjusts Price Target for Liquidia Technologies to $2 From $3, Maintains Neutral Rating	21-05-13	MT
LIQUIDIA : Wedbush Adjusts Liquidia Technologies' PT to $3 From $2, Citing Subcutaneous Treprostinil for Pulmonary Arterial Hypertension; Neutral Rating Kept	21-03-31	MT
LIQUIDIA : Wedbush Adjusts Price Target on Liquidia Technologies to $2 From $4 on Lowered LIQ861/PAH Penetration Rate Estimates; Neutral Rating Kept	21-03-30	MT
LIQUIDIA : HC Wainwright Initiates Liquidia Technologies at Buy With $6 Price Target	20-12-04	MT
LIQUIDIA : Wedbush Cuts Liquidia Technologies to Neutral From Outperform on LIQ861 Regulatory Headwind, LIQ865 US Launch Timeline; PT to $4 From $20	20-11-20	MT